MYCN and neuroblastoma: Based on the International Neuroblastoma Risk Group (INRG) classification system—which takes into account age at diagnosis, histopathological features, MYCN status, DNA index and segmental chromosomal aberrations (SCA)—patients can be placed into a low-, intermediate- or high-risk group.